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 THE IMPACT OF A WHOLE-FOOD, PLANT-BASED DIET ON INTESTINAL 
INFLAMMATION 
CAROL BRUGGEMAN 
ABSTRACT 
There is substantial evidence that the “Western” dietary pattern, a diet defined as being 
relatively high in red and processed meat, total fat, refined/processed foods, and 
relatively lacking in vegetables and fruits, is associated with increased intestinal 
inflammation, which in turn is implicated in the pathophysiology of disease states such as 
inflammatory bowel disease (IBD) and colorectal cancer (CRC). Conversely, there is 
accumulating evidence suggesting that plant-based foods that contain whole grains, 
dietary fiber, antioxidant vitamins, and phytochemicals, have anti-inflammatory effects in 
the gut. However, there is a paucity of research investigating the anti-inflammatory 
effects of a dietary pattern that eliminates all animal products (typical of a Western 
dietary pattern) and is instead entirely plant-based. Such a pattern, which eliminates all 
animal products (including meat, eggs, and dairy), eliminates the foods associated with 
intestinal inflammation and instead replaces them with plant-based foods, many of which 
have been found to be anti-inflammatory.  
The proposed study is a prospective study that will use fecal calprotectin to 
quantify the levels of intestinal inflammation in healthy participants before and after 
shifting them from a predominantly Western dietary pattern to an entirely plant-based 
dietary pattern. This study will help determine whether substituting a plant-based dietary 
pattern for Western dietary pattern decreases intestinal inflammation, thereby supporting 
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its use as a potential treatment modality for those with IBD (in conjunction with or in 
place of pharmaceutical treatment regimens) and as an intervention for primary 
prevention of IBD and CRC.  
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INTRODUCTION 
Background 
Inflammation is the result of an immunological response to substances perceived by the 
intricate components of the body’s innate immune system to be foreign or harmful. 
Through numerous response pathways aimed at ridding the body of harmful substances, 
cells of the innate immune system (such as leukocytes), cytokines and other 
inflammatory mediators, and inflammation-related serum proteins are recruited to the site 
of antigenic attack, producing a local inflammatory state characterized by the cardinal 
signs of tumor, rubor, calor, and dolor (swelling, redness, heat, and pain).1 
The immune response, and subsequent inflammatory state, are regulated by a 
complex interplay of host components and the host microbiome (resident microbes). 
Dysregulation of the immune response and dysbiosis (an imbalance in the host’s 
microbiome) either alone or in combination, can lead to an inappropriate inflammatory 
response.2 Dysbiosis is believed to play a role in diseases of multiple organ systems, 
including the gut.1 Alteration in the balance of the gut’s resident microbes has been 
shown to be impacted by environmental factors such as components of an individual 
host’s diet, and has been implicated as a significant cause of intestinal inflammation.3,4 
In the gut, microscopic manifestations of the inflammatory state include local 
release and recruitment of factors such as the numerous cells of the innate and adaptive 
immune system, cytokines, complement, and prostaglandins.2 Inappropriate continuation 
of the inflammatory state may lead to macroscopic manifestations including mucosal 
lesions/ulcerations in the intestinal lumen, scarring and stricture formation with 
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subsequent narrowing of the bowel lumen, and, in cases of severe Crohn disease, 
transmural defects leading to fistula formation. This in turn produces patient symptoms 
such as abdominal pain, diarrhea, and hematochezia.5,6  
Under the umbrella of inappropriate intestinal inflammation lie the disease states 
of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn 
disease (CD), and colorectal cancer (CRC). Chronic intestinal inflammation (as is seen in 
longstanding IBD) has been identified as an important factor in colorectal 
carcinogenesis.7 Additionally, the prevailing hypothesis of IBD etiology is that, in 
addition to dysregulation of the host immune response, gut dysbiosis can “contribute to 
the initiation and perpetuation of inflammation associated with IBD,”2 although the exact 
pathophysiology remains somewhat unclear. 
The public health burden of both IBD and CRC is not insignificant. In the North 
America, it is estimated that the incidence ranges of UC and CD are 2.2 – 19.2 cases per 
100,000 person-years and 3.1 – 20.2 cases per 100,00 person-years, respectively.8 CRC, 
as a common and deadly disease, carries a remarkable public health burden. Globally, it 
is the third most commonly diagnosed cancer in males and the second in females. Rates 
in North America are among the highest worldwide. In the United States specifically, it is 
estimated that approximately 135,430 cases of large bowel cancer are diagnosed each 
year. Incidence and mortality rates have been increasing in the US, despite our screening 
efforts; approximately 50,260 Americans die of CRC annually, making it responsible for 
about 8 percent of total cancer deaths.9 
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Statement of the Problem 
Given the significant global burden of IBD and CRC, and the shared association of each 
with intestinal inflammation, further study on modifiable risk factors for intestinal 
inflammation is prudent and necessary. As mentioned above, gut dysbiosis has been 
shown to play a significant role in intestinal inflammation.3,4,10–13 In turn, there is 
evidence that gut dysbiosis is impacted by components of the individual host’s diet, with 
research primarily focusing on the differing effects of individual foods or micronutrients, 
which can be broadly categorized as either animal-based or plant-based. Consumption of 
animal-derived dietary components is associated with an alteration of the gut microbiome 
to favor a pro-inflammatory state, while plant-derived dietary components are associated 
with an altered gut microbiome favoring an anti-inflammatory state.13,14  
Animal proteins and fats have additionally been shown to indirectly favor the 
creation of a pro-inflammatory state through downstream effects of pathways activated 
by hyperinsulinemia and COX-2 upregulation.15 Conversely, many plant-derived factors 
including fiber and phytochemicals have been shown to have a direct anti-inflammatory 
effect on the bowel.16–18 
Existing research has focused primarily on individual food items or specific 
micro-/macronutrients rather than the study of a dietary pattern as a whole. Isolation of 
the effect of a specific dietary factor on intestinal inflammation has proven to be 
problematic, as humans do not exclusively consume specific food items or 
micronutrients, but instead consume a dietary pattern with a mixture of components 
interacting to give synergist and additive (or even multiplicative) effects on bowel 
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inflammation. Cho et al. states that “the analysis of individual foods or nutrients does not 
allow for consideration of the complicated interactions or high inter-correlations between 
dietary factors, and the effect of any single nutrient may be too small to detect.”15 To 
avoid this phenomenon of multicollinearity that is inherent in nutritional epidemiology19, 
further research should focus on composite dietary patterns and disease. 
The existing evidence can be characterized by the broad dichotomy of either 
animal-derived or plant-derived dietary factors, with data suggesting the association of 
animal-based foods with a pro-inflammatory state and the association of plant-based 
foods with an anti-inflammatory state. Conveniently, the dietary patterns of a “Western” 
style diet and a plant-based dietary pattern (often referred to as a “vegan” dietary pattern) 
each embody the extremes of this dichotomy. A Western diet is typified by relatively 
high consumption of animal fats and proteins (specifically red and processed meats), 
high-fat dairy products, and refined grains, with relatively low consumption of fruits, 
vegetables, whole grains, fish, and poultry.20 A vegan diet by definition excludes all 
animal products and is instead entirely plant-based.21 Research focusing specifically on a 
vegan diet with emphasis on whole-foods rather than refined or processed foods would be 
of particular benefit.  
While studying a whole-foods, plant-based diet would not elucidate the 
contributions of individual dietary components to intestinal inflammation, given the 
existing evidence, it is not unreasonable to extrapolate that the potentially additive effects 
of exclusion of animal-derived foods and increased consumption of whole grains, dietary 
fiber, vegetables, and fruit may contribute to a decrease in intestinal inflammation, with 
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this in turn having a protective effect on disease states in the gut associated with 
inflammation, namely IBD and CRC. 
 
Hypothesis 
Shifting subjects from a Western dietary pattern to a whole-food, plant-based dietary 
pattern will result in a quantifiable decrease in intestinal inflammation, as measured by 
the intestine-specific inflammatory marker fecal calprotectin. 
 
Objectives and specific aims 
Based on the hypothesis that consumption of animal-derived dietary components is 
associated with a pro-inflammatory state in the gut, while plant-derived dietary 
components are associated with an anti-inflammatory state in the gut, the objective of this 
study is to quantify a decrease in intestinal inflammation resulting from strict 
consumption of a whole-food, plant-based diet. These findings will have potential 
implications for both the primary prevention of CRC, modifiable risk factors for IBD, 
and dietary modifications in the management of IBD. 
Specific aims include: 
• To provide evidence that a Western dietary pattern plays a role in intestinal 
inflammation. 
• To provide evidence that a whole-food, plant-based diet has utility in decreasing 
intestinal inflammation. 
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• To lay the foundation for future study on the utility of a whole-food, plant-based 
diet in the management of IBD and primary prevention of CRC. 
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REVIEW OF THE LITERATURE 
Overview 
Intestinal Inflammation in Disease 
Intestinal inflammation, in its broadest sense, is a result of abnormal host-microbe 
interactions in the gut.22 It is a manifestation of the immune response to substances in the 
gut perceived by the host to be foreign or harmful. In the process of digestion of 
consumed foods and absorption of nutrients, the human intestine is required to 
distinguish between harmless food antigens and infectious or toxic substances or 
organisms. For protection of the host against substances perceived to be harmful, the 
intestine is equipped with an effective barrier, i.e., an intact intestinal epithelium with 
mucus and other secreted protective factors, in addition to the numerous cells and 
molecules of the innate and adaptive immune systems.2  
The innate immune system is composed of cells including neutrophils, 
monocytes, dendritic cells, macrophages, and natural killer cells as well as molecules 
such as complement, C-reactive protein, kinins, and cytokines. Together, these are 
involved in initiation of the immune response to either a pathogenic or commensal 
(resident) microorganism and trigger the response pathways ultimately leading to 
inflammation.2 
The adaptive immune system is composed mainly of B and T lymphocytes, which 
are involved in the immune response to specific foreign antigens. CD4+ T helper cells 
produce and secrete cytokines involved in inflammation and are themselves critically 
important in regulating the inflammatory response at mucosal surfaces such as in the gut.2 
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Immune cells residing in the gut are referred to as gut-associated lymphoid tissue 
(GALT). Epithelial cells, antigen presenting cells (APCs), and other leukocytes in the 
GALT also secrete a number of cytokines which play a role in regulation of responses to 
foreign antigens as well as influencing gut immune homeostasis. Through a complex 
interplay of immune cells such as neutrophils, macrophages, and T cells, pro-
inflammatory cytokines and chemokines are released at the site of insult in the gut, 
leading to an acute inflammatory state.2  
This acute inflammatory state is normally a self-resolving process due to 
intestinal immune system mechanisms which control disproportionate responses to 
microbes in the intestine, whether they be commensal or pathogenic. Proper balance of 
the components of the immune response is key, as either an excessive response or an 
insufficient response will lead to inappropriate intestinal inflammation.2 
In addition to immune dysregulation, composition and quantity of gut microbiota 
has been implicated in inappropriate intestinal inflammation. Studies of animal models 
have shown that intestinal microbiota can play a large role in the initiation of intestinal 
inflammation as well as inappropriate prolongation of the inflammatory response leading 
to chronic inflammation. For example, studies by Hammer et al.3 and Rath et al.4 
demonstrated the involvement of intestinal microbiota in the development of 
inflammation using transgenic germ-free mice, which, when exposed to a defined set of 
bacteria, developed colitis and gastritis. Further studies using mice with null mutations in 
the T-cell receptor expressing a phenotype of spontaneous IBD with cytokine imbalance 
and autoantibody production showed that intestinal inflammation can be initiated by 
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specific organisms or groups of organisms that are normally present in the intestinal 
microbiota.23–25 
In humans, the role of intestinal microbiota in inflammation has been 
demonstrated in clinical experiments in IBD in which diversion of the fecal stream 
improved symptoms in patients with Crohn disease (CD). Clinical experiments have also 
shown that post-operative exposure of the terminal ileum of CD patients to contents of 
the lumen directly lead to increased inflammation. In addition, similar to findings in 
animal models, experiments using cells taken from actively inflamed tissues of IBD 
patients showed that these cells were “activated by exposure to samples of autologous or 
heterologous GI microflora” while cells from normal controls responded only to 
heterologous microflora, indicating that intestinal inflammation might be due to impaired 
host tolerance to antigens normally found in autologous microflora.22 
In addition to abnormal host-microbial interactions causing intestinal 
inflammation, the composition of gut microflora has been shown to differ between IBD 
patients and healthy controls. This implicates both the quantity and content of the gut 
microbiome in disruption of immune homeostasis in the gut and initiation or continuation 
of inappropriate intestinal inflammation. The dysbiosis in IBD patients (when compared 
with healthy controls) has been shown to favor an increase in quantity of bacteria with 
pro-inflammatory properties, a decrease in quantity of bacteria with anti-inflammatory 
properties, and a decrease in complexity of commensal bacteria.3,4  
Specifically, several studies have shown that members of the phyla Bacteroidetes 
and Firmicutes were reduced in patients with IBD.10–12 These human commensal 
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microbes have been shown to have anti-inflammatory effects in cell systems and animal 
models;16 a reduction in quantity of these microorganisms could therefore contribute to 
inappropriate intestinal inflammation. Additionally, pro-inflammatory microbes such as 
entero-adherent and invasive E. coli are found in greater relative abundance and in 
greater frequency in patients with IBD than in healthy individuals, further implicating the 
role of microbes in IBD.  
However, it is unclear whether dysbiosis is a cause of the inappropriate 
inflammatory response seen in IBD or instead an effect of the disease.22 In support of the 
former, studies suggest that diet has a significant effect on alteration of gut microbiota, 
independent of any disease states in the gut. Song et al. notes that switching subjects from 
a “low-fat, plant-rich diet to a Western diet changed microbial composition, metabolic 
pathways, and gene expression in the gut microbiome.”17 Studies of specific dietary 
components have shown that a diet high in animal fats and proteins decreases the quantity 
of Firmicutes13, which, as mentioned above has members with anti-inflammatory 
properties. Firmicutes also play a role in metabolism of dietary plant polysaccharides 
such as dietary fiber.26 Studies of dietary fiber have shown a beneficial effect on the 
structure of gut microbiota via its fermentation product butyrate, a short chain fatty acid 
(SCFA) which is known to have anti-inflammatory, anti-carcinogenic, and anti-oxidant 
properties.17,26  
This interplay suggests that dietary patterns are likely to play a role in maintaining 
a balance of commensal intestinal microbes, which in turn are important players in 
immune and inflammatory responses. Therefore dysbiosis due to an imbalance in dietary 
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components may play a role in initiation of inflammation,17 and consequently, could play 
a role in pathogenesis of disease states such as IBD and CRC, both of which share 
inflammation as an etiologic mechanism. 
 
Patient Presentation 
The symptomatic presentation of intestinal inflammation can have a wide range. In its 
mildest form, as in an acute gastrointestinal (GI) infection, patients can present with self-
limiting symptoms of mild to moderate abdominal discomfort plus or minus nausea, 
vomiting, and/or diarrhea. On the moderate to severe side of the spectrum are the 
inflammatory bowel diseases, Crohn disease and ulcerative colitis, which are chronic 
inflammatory diseases of the intestinal tract with intermittent acute flares of symptoms. 
Crohn disease is characterized by transmural inflammation (inflammation 
occurring through the entire wall of the intestine). Any portion of the GI tract can be 
involved, with lesions skipping from mouth to anus. Symptoms include crampy 
abdominal pain, diarrhea with or without blood, weight loss, and frank blood per rectum. 
Severe disease can also cause malabsorption resulting in nutrient deficiencies and/or 
weight loss, fistula formation, and luminal narrowing due to fibrotic strictures which can 
result in constipation and in some cases bowel obstruction.5 
  Ulcerative colitis, as its name implies, is limited to the colon and is characterized 
by recurrent episodes of inflammation limited only to the mucosal layer. It commonly 
involves the rectum and may extend proximally in a continuous fashion to other regions 
of the colon. Patients most frequently present with diarrhea, which may or may not be 
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bloody. Associated symptoms include colicky abdominal pain, urgency, tenesmus, and 
incontinence. Severe cases may result in anemia due to profound blood loss or bowel 
perforation as a consequence of toxic megacolon.6 
 
Intestinal Inflammation and IBD Pathogenesis 
Although the exact pathogenesis of IBD remains unclear, the prevailing hypothesis at this 
time is that a dysregulated host immune system due to underlying genetic defects coupled 
with alterations in host intestinal bacteria contribute to the initial development and/or 
continuation of intestinal inflammation.2 In short, this dysregulated immune response 
involves genetic defects (such as in CARD15, which is involved in innate immunity)27 as 
well as impaired and/or incorrect migration (“homing” of B and T cells to the gut in 
response to a microbial or dietary antigen).2 In the overall picture of gut dysbiosis, no 
single microorganism has yet been identified to have a consistent association with IBD. 
However, specific microbial components, such as the polysaccharide A tail of the 
commensal microbe Bacterioides fragilis, and products of microbial fermentation, such 
as SCFAs, are means through which the gut microbiome can influence both the intestinal 
immune response and intestinal inflammation.2  
Aside from genetic susceptibility, environmental factors have been implicated to 
play a role in the development of IBD, in particular diet. Andersen et al. state that the 
high rate of both symptomatic and endoscopic remission induced by enteral nutritional 
therapy “suggests a major effect of diet on intestinal inflammation.” They propose 
several biologically plausible mechanisms through which diet might affect risk of IBD, 
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namely through the effect of dietary components on gut homeostasis via oxidative stress, 
alteration of transcription factors involved in regulating intestinal inflammation, and by 
modulating mediators of the inflammatory response.16  
In addition, incidence of IBD has been increasing in both developed and 
developing countries, in parallel with adoption of a “Western” diet, which is high in fat 
and protein but low in fruits and vegetables.28,29 For example, the increased incidence of 
IBD in Japan in recent decades has been strongly correlated with increased intake of total 
animal and milk protein, total fat, animal fat, N-6 PUFAs (predominantly found in animal 
food sources), and relatively decreased intake of N-3 PUFAs (predominantly found in 
fish and plant food sources) in the Japanese population.16,28 Additionally, research has 
shown increasing incidence of IBD in populations who emigrate from the developing 
world to developed countries.30 These findings have not been explained by the recent 
genetic discoveries in IBD pathogenesis28 and indicate the importance of modifiable 
environmental risk factors involved in the development of IBD.  
In particular, diet-related intestinal inflammation has been suggested to play a role 
in IBD pathogenesis via mechanisms other than alteration of the gut microbiome. Animal 
models of IBD have shown that fatty acids, dietary fibers, and phytochemicals lessen 
intestinal inflammation.16 Chapman-Kiddell et al. note that the components of a standard 
“Western” diet could contribute to intestinal inflammation via mechanisms such as the 
effects of insulin resistance and modification of intestinal permeability.28 Furthermore, 
these authors note that a Western diet is associated with obesity, which has been 
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recognized as a chronic inflammatory state and could potentially increase risk of IBD in 
genetically susceptible individuals.28 
In a systematic review of studies on pre-illness diet and subsequent risk of 
developing IBD, Hou et al. revealed that high intake of total fats, poly unsaturated fatty 
acids (PUFAs), omega-6 fatty acids, and meat (standard components of a Western style 
diet) were consistently associated with increased risk of developing both UC and CD; 
high vegetable intake was consistently associated with decreased risk of UC; and fiber 
and fruit intake were consistently associated with reduced risk of CD. These authors 
propose that diet could modulate intestinal inflammation via mechanisms such as antigen 
presentation and alteration in prostaglandin balance.29  
 
Intestinal Inflammation and CRC Pathogenesis 
Chronic intestinal inflammation, whether as a result of longstanding IBD or of other 
factors, has long been implicated in the pathogenesis of CRC.15 Indeed, Coussens et al. 
states that the “strongest association of chronic inflammation with malignant diseases is 
in colon carcinogenesis arising in individuals with IBD.”7 Inflammatory cells 
predominate the neoplastic microenvironment. Tumor cells take over specific molecules 
of the innate immune system, including selectins, chemokines, and their receptors 
(factors involved in the inflammatory response) for invasion, migration, and metastasis. 
Furthermore, disruption of normal cell death and repair occurs in chronically inflamed 
tissues, leading to DNA replication and proliferation of cells that are no longer under host 
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control of normal growth. An environment abundant in inflammatory cells therefore 
supports uncontrolled cell proliferation and neoplastic growth.7 
While genetic factors are an additional known risk factor for CRC, accumulating 
evidence suggests that a considerable proportion of CRC cases are due to environmental 
factors, most notably diet-induced intestinal inflammation.15,31,32 Similar to incidence of 
IBD, incidence of CRC is highest in high-income, industrialized, developed countries; is 
increasing in developing countries; and is greater among individuals who emigrate to 
developed countries which have high incidences of CRC as compared to populations who 
remain in lower income, less industrialized countries, implicating a significant influence 
of dietary and lifestyle factors.31,33 Chan et al. states that CRC incidence increases “in 
parallel with economic development and adoption of a Western lifestyle,”33 with a 
“Western lifestyle” typified by a diet high in animal proteins and fats and processed food, 
in addition to a relatively sedentary activity level.31  
Fung et al. estimates that the majority (at least 80%) of CRC cases are “inducible 
and could be prevented with changes in diet and lifestyle.”31 There is also 
epidemiological evidence indicating that 30% to 70% of all CRC cases “attributable to 
diet, with red and processed meat intakes implicated as important dietary factors.”32 
Moreover, an estimate by Sansbury et al. states that “patient-specific differences in diet 
are responsible for more variation in CRC than any other factor and could account for up 
to 90% of CRC deaths in the US.”34  
A case-control study by Cho et al. on dietary inflammatory index (DII), which 
assesses the inflammatory potential of a dietary pattern, and risk of CRC demonstrated 
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that higher dietary inflammatory index scores were associated with an increased 
incidence of CRC, suggesting that a pro-inflammatory diet is involved in colorectal 
carcinogenesis. This is in line with several studies showing an association between higher 
DII scores and CRC, including the Iowa Women’s Health Study35 and the Women’s 
Health Initiative36 reporting that individuals in the highest quintile of DII were at a 20% 
increased risk of CRC. Another US cohort study demonstrated a 40% increased CRC risk 
associated with the highest quartile of DII scores.37 Two case-control studies conducted 
in Italy38 and Spain39 similarly demonstrated increased CRC risk associated with 
increased DII scores. 
There are several biologically plausible mechanisms in which diet-related 
inflammation can induce colorectal carcinogenesis. Inflammation can induce insulin 
resistance and subsequent increased circulating levels of insulin, glucose, triglycerides, 
and non-esterified fatty acids. These growth-promoting factors provide a proliferative 
environment to epithelial cells in the colon and also expose them to reactive oxygen 
intermediates, ultimately resulting in the promotion of CRC.15,40,7  
Activation of the COX-2 pathway can cause local cell proliferation, angiogenesis, 
and mutagenesis via activation of inflammatory cells which generate reactive oxygen 
intermediates (ROIs) that are mutagenic and mitogenic.15,40 The COX-2 pathway can be 
activated by inflammatory cytokines (e.g., IL-6) and growth factors. It should be noted 
that higher DII scores have been found to be associated with inflammatory cytokines, 
specifically IL-6 and C-reactive protein. COX-2 can conversely be downregulated by 
dietary components such as vitamin D, antioxidants, and n-3 fatty acids.15 
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Dietary components themselves can have a direct effect on colorectal 
carcinogenesis via inflammation. Pro-inflammatory diets high in red and processed meats 
are often high in N-nitroso compounds, which potentially promote DNA damage. Anti-
inflammatory diets high in fruits and vegetables contain antioxidants and micronutrients 
which possess anti-neoplastic properties. Diets high in fiber also lessen intestinal transit 
time of consumed food, therefore resulting in decreased contact time between 
carcinogens present in food and the colonic epithelial cells.15 
Diet-induced inflammation, therefore, is a significant and modifiable risk factor 
for colorectal carcinogenesis, as dietary components affecting CRC risk are consistently 
associated with their pro-inflammatory potential. Evidence suggests that specific dietary 
components play a role in inflammation. Fruit, vegetable, fiber, and moderate alcohol 
intake may decrease inflammation, while red meat, processed meat, and fat may increase 
inflammation.15  
Furthermore, Song et al. proposes that “diet likely influences colorectal 
carcinogenesis through several interacting mechanisms” including “direct effects on 
immune responsiveness and inflammation and indirect effects of over-nutrition and 
obesity.” These authors also cite emerging evidence that demonstrates involvement of the 
intestinal microbiome in the relationship between diet and cancer.17 It is important to note 
that immune dysregulation, intestinal inflammation, obesity, and gut dysbiosis are all 
players in IBD pathogenesis as well. Therefore, studies focusing on the effect of diet-
induced intestinal inflammation will have impacts on prevention of both CRC and IBD. 
 18 
The following section will focus on specific dietary components with either pro- or anti-
inflammatory effects on the gut. 
Existing research 
The Relationship Between Diet and Intestinal Inflammation 
Much of the existing research on intestinal inflammation associated with diet has focused 
on specific dietary components and association with risk of IBD or CRC. As research has 
tended to focus on the study of an individual food item or macronutrient, many studies 
have yielded inconclusive results, likely due to interacting and potentially confounding 
effects of individual food items on each other. There are, however, specific 
macronutrients or food items that have been found to be either positively or negatively 
associated with inflammation when results are adjusted for potential confounders. 
 
Pro-inflammatory Foods/Food Components 
Red and processed meat 
Red meat “refers to any unprocessed mammalian muscle meat that has a red color when 
raw,”41 and usually includes beef, veal, lamb, mutton and pork.33,42 Heme iron, a 
component of red meat, has been shown to induce oxidative stress,17 which is defined as 
“an imbalance between production of free radicals and reactive metabolites, so-called 
oxidants or reactive oxygen species (ROS), and their elimination protective mechanisms, 
referred to as antioxidants.”43 Oxidative stress can in turn can induce inflammation. This 
is supported clinically by a prospective cohort study of UC patients in remission by 
Jowett et al. which showed that meat intake, particularly red and processed meat, was 
 19 
associated with increased risk of relapse (acute symptomatic flares of intestinal 
inflammation).44  
Another pro-inflammatory compound found in red meat is N-glycolylneuraminic 
acid (Neu5Gc), a silica acid found in lamb, pork, and beef, as well as cow milk. Since 
humans do not possess the gene encoding the enzyme required for synthesis of Neu5Gc, 
dietary intake is our only source of this compound. Unlike the immune systems of many 
other vertebrates in whom synthesis of Neu5Gc naturally occurs, the human immune 
system does not recognize this compound, thus treating it as a foreign substance and 
subsequently triggering an immune response.41 It is thought to promote chronic 
inflammation in the gut via anti-Neu5Gc antibodies.45 Although there is a biologically 
plausible role for Neu5Gc for chronic intestinal inflammation and therefore a potential 
contribution to development of IBD and CRC, there is currently a lack of epidemiological 
data. 
Red meat has also been deemed “probably carcinogenic” to humans for cancers 
including CRC by the 2015 International Agency for Research on Cancer’s World Cancer 
Report.46 This is in line with findings from the 2011 Colorectal Cancer Report stating that 
there is convincing evidence that red and processed meat increases risk of CRC.47 
However, it is unclear whether the mechanism is directly through inflammation. 
Processed meat is defined by Jeyakumar et al. as “meat that has been modified to 
enhance flavor or improve preservation through methods such as salting, curing, 
fermentation, and smoking.”41 Meats fitting these criteria usually include ham; sausages; 
hamburgers; smoked, cured, and salted meat (e.g., bacon); and canned meat.42 Inorganic 
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sulfur is commonly used as a preservative in processed meat; sulfur-containing amino 
acids are also found in red meat and animal proteins in general. In the gut, sulfur is 
metabolized by hydrogen sulfide (H2S) by resident bacteria. H2S has been implicated in 
intestinal inflammation in UC and has also been implicated in the pathogenesis of CRC, 
as excess chronic H2S exposure in the colon is associated with inflammation and 
modification of immune function.17 Additionally, a 2010 case-control study of pre-illness 
diet and risk of IBD by Maconi et al. demonstrated that increased intake of processed 
meat is associated with increased risk of CD.48 
 
Excess protein/meat 
Increased consumption of meat in general, whether it be red or white meat, is associated 
with increased sulfide levels, indicating that meat is a critical substrate for sulfide-
producing bacteria in the colon. As mentioned above, sulfide is associated with an 
increase in intestinal inflammation.  
Epidemiological data and clinical studies have shown a positive association of 
increased animal protein/meat intake with increased risk of IBD. For example, there was 
a strong correlation between increased CD incidence and increased consumption of 
animal and milk protein in Japan.28 A prospective cohort study by Jowett et al., 
demonstrated that increased meat and protein intake increased the likelihood of relapse of 
UC in patients in remission.44 A large French prospective study showed that high total 
protein intake, specifically from animal sources, was associated with increased risk of 
IBD.49  Despite a relatively small number of studies, there is some data supporting a 
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relationship between excess protein/meat intake and intestinal inflammation (with IBD as 
the studied outcome), with the proposed mechanism being via the action of gut bacteria 
and their products. 
In this same vein, Andersen et al. suggests that meat has the potential to deliver 
bacteria such as Yersinia which have been implicated in the pathogenesis of CD. These 
authors also suggest that antibiotics, which are used in extensive amounts in animal 
agriculture, may still be present in meat products. These antibiotics could theoretically 
alter the gut microflora and thus have the potential to be involved in inappropriate 
inflammation.16 
 
Fats 
A high-fat diet is implicated in intestinal inflammation via its induction of changes in the 
gut microbiome with subsequent changes in immune and inflammatory cells in the gut. 
Individual fatty acids have specific effects on the inflammatory response.28 Experimental 
data have shown that, in particular, omega-6 PUFAs have pro-inflammatory effects, 
which are likely due to antagonism of the anti-inflammatory effects of omega-3 PUFAs.17 
Furthermore, omega-6 PUFAs, including linoleic acid and arachidonic acid, are 
metabolized in the gut to pro-inflammatory eicosanoids (like prostaglandins, leukotrienes, 
and thromboxane). Arachidonic acid in particular specifically stimulates inflammation by 
disruption of intestinal tight junction molecules, thus leading to disruption of the 
intestinal barrier, as well as induction of the inflammatory response via inflammatory 
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cytokines and free radicals. It is important to note that arachidonic acid has been found in 
high levels in the colonic mucosa of IBD patients.16  
Dietary sources of omega-6 PUFAs include poultry, eggs, mayonnaise, dairy, 
processed pork products (e.g., sausage, ham, bacon, etc.) and fatty cuts of beef and 
chicken, in addition to many oils from plant sources. In support of this experimental data 
is epidemiological data from Japan indicating a strong correlation between the recent 
increased incidence of CD and increased intake of total fat, animal fat, and omega-6 
PUFAs.28 Studies of pre-illness diets and IBD have also shown that high intakes of 
PUFAs were associated with an increased risk of both UC and CD.50,51 Furthermore, 
analyses of the fatty acid makeup of adipose tissue demonstrated that a high baseline 
level of arachidonic acid is associated with a four-fold increased risk of UC development 
in a statistically significant dose-response manner, thus suggesting a causal effect of this 
fatty acid on intestinal inflammation.16 
 
Anti-inflammatory Foods/Food Components 
Dietary fiber and whole grains 
Sources of dietary fiber are exclusively plant-based foods. Foods containing the highest 
amount of dietary fiber per weight include cereals; beans; legumes such as split peas, 
chickpeas, and lentils; pumpkin seeds; and fruits and vegetables such as artichokes, pears, 
avocados, and apples.52 Resident bacteria in the gut ferment resistant starch in dietary 
fiber to short-chain fatty acids (SCFAs). Butyrate is the major SCFA produced by 
bacterial fermentation in the colon. It has been shown to have anti-inflammatory effects 
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via its inhibition of NFκβ, which subsequently prevents transcription of pro-
inflammatory cytokines.28 SCFAs additionally have modulatory effects on the immune 
system, which Song et al. proposes influences GI and potentially systemic health.17 
Furthermore, high-fiber diets as a whole are known to favorably modulate the gut 
microbial community, therefore playing a role in the balance between homeostasis and 
inflammation. Studies have also demonstrated a role for dietary fiber in preventing 
translocation across the intestinal mucosa. Translocation of E. coli isolates from CD 
patients and healthy controls was inhibited by certain soluble dietary fibers, which may 
prove beneficial since one of the pathogenic mechanisms of IBD is thought to involve 
disruption of the intestinal barrier. Moreover, experimental models of high fiber diets in 
animals have been shown to improve inflammation in colitis.16 
Grains which are refined or processed retain only the endosperm. In contrast, 
whole grains contain the components of germ and bran, which are significant sources of 
various substances such as fiber, antioxidants, and phytochemicals which have a 
potentially anti-inflammatory effect. In addition, dietary consumption of whole grains is 
associated with decreased insulin resistance and subsequent decreased fasting levels of 
insulin.17 As described above, hyperinsulinemia and its resultant increase in circulating 
growth factors has been associated with increased inflammation. 
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Vitamins 
Vitamin D 
Vitamin D, in its active form (1,25(OH)2D), is involved in attenuation of inflammation 
via its effects on the innate immune system. Vitamin D stimulates the synthesis of 
cathelicidin and some defensins, which are antimicrobial peptides involved in the innate 
immune system located on the epithelial surface of the GI tract. These molecules have 
antibacterial, antiviral, and antifungal effects and also have functions in chemotaxis and 
cytokine and chemokine regulation. Their main function is to protect the host from 
microbial growth and inflammation, supporting that a critical action of vitamin D is 
immune regulation. This is supported by studies suggesting that dysregulated induction of 
defensins and cathelicidin occurs in CD.53 Andersen et al. further report that the higher 
incidence of CD seen in northern regions of the world could be due to vitamin D 
deficiency caused by less sunlight exposure.16 Experimental animal models using mice 
with colitis have also shown improvement in intestinal inflammation following 
consumption of a diet high in vitamin D.17 
There are very few foods which are naturally high in vitamin D. It is possible for 
human keratinocytes to synthesize necessary vitamin D with adequate sun exposure. 
Fatty fish such as salmon, tuna, and mackerel are among the best dietary sources of 
naturally occurring vitamin D.  The majority of vitamin D in the American diet comes 
from fortified foods such as dairy and non-dairy milk as well as ready-to-eat breakfast 
cereals.54 
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Vitamin A 
There are two forms of vitamin A in the human diet: preformed vitamin A (retinol) and 
the provitamin A carotenoids. Preformed vitamin A is found mainly in animal sources; its 
concentrations are highest in liver and fish oils. The majority of provitamin A sources are 
plant foods such as leafy green vegetables like spinach; orange and yellow vegetables 
such as sweet potatoes, squash, and carrots; tomatoes and tomato products; fruits such as 
mangos and apricots, and some vegetable oils. Both preformed and provitamin A must be 
intracellularly metabolized to the active forms of retinal and retinoic acid in order for the 
biological functions of vitamin A to be supported.55 
Retinoic acid is important in the appropriate induction of B and T cells in the 
immune response to consumption of microbial and dietary antigens. In the presence of 
retinoic acid, dendritic cells of the innate immune system are signaled to induce 
regulatory T cells. However, in an environment lacking retinoic acid, dendritic cells 
instead induce Th17 cells, thus triggering an inflammatory response via the cytokine IL-
17. Retinoic acid also plays an important role in the appropriate translocation, or homing 
of antigen-presenting B and T cells to the gut, as evidenced by impaired migration of B 
and T cells to the gut in rats deficient in vitamin A.16 As described above, impaired 
homing of B and T lymphocytes is a mechanism postulated to be involved in IBD 
pathogenesis.2  
The provitamin A carotenoid beta carotene is referred to as an antioxidant nutrient 
due to its protective effects against oxidative stress caused by reactive oxygen species. Its 
antioxidant effects therefore ultimately protect cells against inflammation as well.17 
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Vitamin C  
Vitamin C is also considered an antioxidant and anti-inflammatory nutrient.17 In addition 
to its direct antioxidant effects, vitamin C is also capable of regenerating antioxidants in 
the human body, including vitamin E.56 Case-control studies have also demonstrated an 
inverse association between vitamin C intake and many cancers, including CRC.57,58 It is 
thought that this is due to its protective effects against oxidative damage that could 
potentially play a role in carcinogenesis. However, evidence for a protective effect from 
prospective studies and randomized clinical trials against cancer risk has been 
inconsistent.56  
Fruits and vegetables are the best dietary sources of vitamin C; those with the 
highest concentrations of vitamin C per mg are bell peppers, oranges and orange juice, 
grapefruit juice, kiwis, broccoli, strawberries, brussel sprouts, tomato juice, and 
cantaloupe.56 
 
Vitamin E 
Another antioxidant and anti-inflammatory nutrient is vitamin E, or alpha-tocopherol.17 It 
specifically halts the production of ROS formed from oxidation of dietary fat. Its role in 
prevention of chronic diseases associated with oxidative stress is currently under 
investigation. Plant foods such as nuts, seeds, vegetable oils, and green leafy vegetables 
are some of the best dietary sources of vitamin E.59 
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Omega-3 polyunsaturated fatty acids 
Omega-3 PUFAs are found in fish and fish oils as well as plant oils such as flaxseed, 
soybean, and canola. Dietary omega-3 PUFAs are metabolized to anti-inflammatory 
molecules including prostacyclins, lipoxins, and epoxy-eicosatrienoic acids in the gut.16 
Experimental data has shown that omega-3 PUFAs attenuate the inflammatory response 
via inhibition of the conversion of arachidonic acid to pro-inflammatory eicosanoids, 
suppression of inflammatory cytokines, and downregulation of genes involved in 
inflammation.28 Prospective studies of UC have found a non-significant protective effect 
on consumption of omega-3 PUFAs on UC development. Andersen et al. cite evidence of 
decreased risk of cardiovascular disease associated with omega-3 PUFAs to extrapolate 
that omega-3 PUFAs could have anti-inflammatory effects in other inflammatory disease 
states such as IBD.16  
 
Allyl sulfur and sulfur-containing glycosides 
Sulfur-containing glycosides (mainly glucosinolates) found in cruciferous vegetables like 
cabbage, brussel sprouts, and broccoli are known to have anti-inflammatory effects in the 
gut, in contrast to inorganic sulfur and sulfur-containing amino acids described above. 
Allyl sulfur, found in garlic, also has anti-inflammatory effects in the gut via reduction of 
oxidative stress. 
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Phytochemicals obtained from whole fruits and vegetables 
Phytochemicals are defined as the non-nutrient plant compounds in fruits, vegetables, 
grains, and other plant foods.18 Under this umbrella are compounds including carotenoids, 
polyphenolic acids, flavonoids, and stilbenes/lignans. These plant-based compounds are 
known to have antioxidant and anti-inflammatory effects. Diets rich in fruits and 
vegetables are thus hypothesized to play a major role in protection against numerous 
chronic disease states which are induced by oxidative stress and subsequent 
inflammation.18,60  
Eberhardt et al. propose that the additive and synergistic effects of the complex 
mixtures of phytochemicals in whole fruits and vegetables, as opposed to isolated 
phytochemicals, are responsible for their antioxidant properties,61 as individual 
antioxidants studied as supplements in clinical trials have shown inconsistent results. 
Indeed, the hypothesis that dietary antioxidants decrease the risk of certain chronic 
diseases was formed from epidemiological studies of whole fruits and vegetables.18 For 
example, studies have shown that consumption of green and yellow vegetables and fruit 
is associated with decreased cancer risk. These fruits and vegetables are rich in beta-
carotene; when studied in isolation however, beta-carotene has not shown the same 
protective effects.18 
As an additional example, an experimental model by Liu et al. estimates that the 
vitamin C in apples with skin is responsible for only 0.4% of the total antioxidant activity 
of this fruit, indicating that it is the combination of phytochemicals in fruits and 
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vegetables, as opposed to an isolated antioxidant such as vitamin C, that is responsible for 
the majority of their antioxidant effects.18  
As the estimated 8,000 different phytochemicals present in whole foods each 
differ in molecular size, polarity, and solubility, it is plausible that each differs in 
bioavailability and effect on different cells, organs, and tissues. Liu et al. states that “pills 
or tablets simply cannot mimic this balanced natural combination of phytochemicals 
present in fruit and vegetables,” as the bioavailability of the isolated compound may be 
attenuated or lost.18 
Studies have suggested biologically plausible synergistic mechanisms of action of 
phytochemicals such as scavenging of oxidative agents and alteration of the immune 
response.18 A postulated protective mechanism of phytochemicals specific to IBD 
development is that flavonoids may be involved in the intestinal immune system’s first 
line of defense, i.e., an effective barrier.2 Flavonoids seem to play a role in the 
preservation of intestinal intercellular tight junctions,16 the disruption of which is 
hypothesized to be involved in the impairment of the intestinal barrier function 
implicated in IBD pathogenesis.2 
 
Studying the whole dietary pattern 
In line with Liu et al.’s rationale to study whole fruits and vegetables in order to 
accurately ascertain the effects of synergistic phytochemicals, accumulating evidence 
supports the utility of studying dietary patterns as a whole, as opposed to individual 
dietary components. Nutritional epidemiology is inherently subject to multicollinearity, a 
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statistical phenomenon which can occur when two or more independent variables are 
highly correlated, and which often leads to difficulty elucidating the independent effects 
of an individual dietary component. This often occurs in studies of foods and nutrients, as 
“diet is a complex mixture of foods, nutrients, and other dietary constituents” with 
potentially additive or even multiplicative effects.19 Song et al. suggest that studying a 
combination of nutrients and foods may demonstrate more robust results associated with 
disease pathogenesis, specifically noting that different nutrients with either pro- or anti-
inflammatory effects may work together to influence inflammation through overlapping 
pathways.17 These authors also state that the substitution of favorable dietary components 
for detrimental foods, not merely the addition of beneficial foods, is of critical 
importance. Therefore, shifting to a new dietary pattern overall is likely necessary for 
significant effects on human health.  
In their study of eating patterns and risk of CRC, Slattery et al. revealed that 
analysis of entire dietary patterns allowed significantly stronger characterization of whole 
eating patterns with risk of disease than individual dietary components alone. Their 
results showed that the consumption of meat had a minimal effect on CRC risk. However, 
when considering an eating pattern as a whole, they found that a Western diet is 
associated with increased risk beyond that seen in the individual food components that 
comprise a Western diet. The risk associated with a composite eating pattern was more 
consistent and robust than risk associated for individual food items. This indicates that 
“the overall pattern of a diet may have a greater effect on health than any one food.”20  
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Cho et al. agree that “the analysis of individual foods or nutrients does not allow 
for consideration of the complicated interactions or high inter-correlations between 
dietary factors, and the effect of any single nutrient may be too small to detect. 
Combining dietary factors, such as dietary patterns, may overcome these limitations.”15 
Their study design using the dietary inflammatory index integrates individual dietary 
components to analyze the inflammatory effects of an entire diet. These authors note that 
the study of a whole dietary pattern could “be used without concern regarding dietary 
intercorrelations and the particular dietary culture of the study population.”15 
Similarly, Wirfalt et al. contend that “the true effect of diet may only be observed 
when all components are considered simultaneously,” as the dietary components of foods 
consumed together are subsequently metabolized together and therefore are likely to act 
synergistically in their effects on the host’s health. They state that because of this, studies 
of individual foods or micronutrients are an “inefficient approach in nutrition 
epidemiology” and suggest cluster analysis, a pattern methodology similar to the methods 
utilized by Slattery et al., may “turn the analytical difficulties into an advantage” by 
taking into account the composite effects of dietary components which comprise a certain 
dietary pattern. These authors specifically note this advantageous effect when the 
hypothesized association between diet and disease includes the effects of non-energy 
contributing plant foods, as their “use of density variables based on consumption 
frequency and standardized to have the same variance allowed food patterns 
characterized by low energy foods to emerge”62 This would be especially useful in the 
study of phytochemicals, in line with Liu et al.’s proposition that the effects of these 
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compounds are greatly attenuated when analyzed individually as opposed to as 
components of whole plant foods, described above.18 
Furthermore, Flood et al. also note the advantage of a diet patterns approach to 
nutritional epidemiology in order to “capture the totality of dietary experience, including 
all the nutrient interactions, in a manner that studies of single nutrients or individual 
foods cannot.” Their 2008 study of diet and CRC risk identified two dietary patterns 
ubiquitous in several dietary pattern-CRC studies conducted in numerous countries 
throughout the world prior to theirs: the fruit and vegetable pattern and the meat and 
potatoes pattern. Their findings were consistent with the results of the majority of these 
studies and indicated that the fruit and vegetable pattern was associated with a reduced 
risk of CRC while the meat and starch pattern was associated with increased risk of CRC. 
This data is of particular importance as the common observations of these studies 
remained highly stable over time and despite different geographical locations and 
cultures and the use of different food frequency questionnaires (FFQs) among studies.63  
When considering the existing research on the effect of individual dietary 
components on intestinal inflammation, it becomes apparent that pro-inflammatory foods 
are largely animal-based and are foods typified by a Western dietary pattern, while anti-
inflammatory foods are almost exclusively plant-based. Therefore, a Western diet and a 
vegan (plant-based) diet conveniently embody the extremes of this animal-food versus 
plant-food dichotomy and present a novel area of study. In particular, the quantifiable 
effects on intestinal inflammation after shifting individuals from a primarily Western type 
dietary pattern to a whole-food, plant-based dietary pattern would be of utility, as 
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intestinal inflammation is a common pathogenic mechanism in the disease states of IBD 
and CRC, both of which carry a large public health burden. A comparison between these 
two dietary patterns is found in Table 1 below. 
 
Table 1: Western Diet vs Vegan/Plant-Based Diet 
 
 
Markers of Inflammation 
Currently, the most sensitive and specific marker of intestinal inflammation is fecal 
calprotectin, a calcium- and zinc-binding protein, which is able to provide a quantitative 
measure of intestinal inflammation. It is considered specific to neutrophils and is 
inflammation- rather than disease-specific; an elevated measurement is indicative of 
intestinal inflammation due to any cause. The amount of calprotectin detected reflects the 
amount of neutrophils involved in inflammation, thus providing a noninvasive 
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measurement of neutrophil recruitment to the intestine in the inflammatory process.64 
Calprotectin is therefore significantly associated with IBD and CRC.65 
It is currently used as a prognostic and diagnostic tool for IBD and carries a 93% 
sensitivity and 94% specificity for IBD.66 Most studies report the normal range to be 
between 10-60 mcg/g. Values over 50-60 mcg/mg are generally considered abnormal. 
Values over 200 mcg/g have a higher predictive value for pathology and values in the 
range of 500-600 mcg/g nearly guarantee pathological findings.64 
As a non-invasive marker of inflammation, fecal calprotectin minimizes the 
number of patients having to undergo an invasive endoscopy in the work up of 
suspected IBD, as a large proportion of patients with suspected IBD have no 
findings on endoscopy.65 It also reliably predicts clinical relapse with an 80% 
sensitivity in patients with an established diagnosis of IBD.64 Its role in screening, 
diagnosis, and prognosis of CRC is currently under investigation.67  
 35 
METHODS 
Study design 
This study will be a prospective cohort study quantitatively measuring intestinal 
inflammation using fecal calprotectin in healthy participants before and after shifting 
from a primarily Western dietary pattern to a whole-food, plant-based diet. 
Study population and sampling 
Healthy participants will be recruited over a period of twelve months from outpatient 
primary care clinics of Boston Medical Center. Inclusion and exclusion criteria are shown 
in Table 2. Eligible participants will be identified as primarily consuming a Western 
dietary pattern by completion of a semi-quantitative food frequency questionnaire (FFQ), 
described below. We define a Western dietary pattern as relatively high intake of red and 
processed meat, high-fat dairy products, eggs, refined grains, processed foods, and high-
sugar snacks and beverages, and relatively low intake of fruits, vegetables, legumes, 
whole grains, seafood, and poultry.  
After identifying eligible participants, a sample size of 268 individuals will be 
included in the study using sample size calculations that assume a 10% decrease in fecal 
calprotectin given 90% power and alpha level 0.05. 
 
Table 2: Inclusion and Exclusion Criteria for Healthy Participants 
Inclusion Exclusion 
1. All participants will be over the 
age of 18 and able to provide 
informed consent. 
2. All participants will be 
1. Individuals with a diagnosis of 
ulcerative colitis, Crohn disease, 
irritable bowel syndrome, or 
individuals with recent or current 
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identified as consuming a 
primarily Western dietary 
pattern. 
symptoms of IBD or IBS. 
2. Individuals with diagnosis of celiac 
disease. 
3. Individuals with diagnosis of cystic 
fibrosis. 
4. Individuals with history of or 
current diagnosis of colorectal 
cancer. 
5. Individuals with a family history or 
personal history of Lynch syndrome 
or FAP. 
6. Current smokers. 
7. Excessive use of ethanol (>1 drink 
per day for women, >2 drinks per 
day for men). 
8. Chronic use of NSAIDs or aspirin. 
9. Individuals with a GI infection 
within 4 weeks of beginning the 
study period. 
10. Recent use of antibiotics within 4 
weeks of beginning the study 
period. 
11. Individuals who exercise greater 
than 5 times per week. 
12. Use of dietary supplements 
including vitamins, minerals, and 
fish oil. 
13. Pregnant women (due to 
recommendations for folic acid 
supplementation during pregnancy). 
 
Intervention 
Participants will be asked to abstain from eating all animal products including meat, eggs, 
and dairy and will be switched to a whole-food, plant-based diet for a study period of 
twelve weeks. All participants will be provided three whole-food, plant-based meals per 
day, free of charge, for the entirety of the study period.  
 37 
After the study period, participants will have the option of purchasing whole-
food, plant-based meals to continue this dietary pattern or resuming their pre-intervention 
diet. This potentially provides the opportunity for a follow-up study to evaluate whether 
intestinal inflammation, as quantified by fecal calprotectin, increases after participants 
resume their baseline dietary pattern. 
Study variables and measures 
The primary outcome will be amount of decrease in intestinal inflammation, as quantified 
by fecal calprotectin levels. Fecal calprotectin concentrations less than or equal to 50 
mcg/g indicate absence of active intestinal inflammation, concentrations between 50.1 
and 120.0 mcg/g are considered borderline and may represent a mild inflammatory 
process in the gastrointestinal tract, and concentrations greater than or equal to 120.1 
mcg/g are suggestive of significant active intestinal inflammation. The mean value in 
healthy adults is approximately 25 mcg/g with a standard deviation of 6 mcg/g.68 
Recruitment 
Healthy participants who meet the inclusion and exclusion criteria will be recruited from 
the outpatient primary care clinics of Boston Medical Center. Fliers providing details of 
the study and contact information for the research team will be placed at the front desk 
and waiting areas of participating clinics. Healthcare providers at these clinics will also 
be informed and educated about the study and its inclusion and exclusion criteria in order 
to facilitate patient participation. Interested patients will be instructed to contact the 
research team and will then be provided further details of the study, including risks and 
benefits, as well as the FFQ described below to determine eligibility in the study. 
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Our FFQ will include 131 food items with specified serving sizes as previously 
described by Hu et al.69 Food items and food groupings used in the FFQ can be found in 
the appendix. For each food item, participants will indicate the average frequency of 
consumption over the past one year, with options including “never,” “almost never,” “1-2 
times per month,” “1-2 times per week,” “4-6 times per week,” “once per day,” “1-2 
times per day,” “4-6 times per day,” “>6 times per day.” 
At the end of the twelve-month recruitment period, a complete list of patients 
identified as primarily consuming a Western dietary pattern by their FFQ will be put 
through a randomization software program to randomly select the sample size calculated 
above. These patients will be contacted by the research team and asked to provide 
informed consent for participation in the study. 
Data collection 
Prior to beginning the whole-food, plant-based dietary intervention, participants will 
provide a stool sample for analysis of baseline fecal calprotectin. Additional stool 
samples from each participant will be collected at weeks six and twelve of the study 
period for repeat analyses of fecal calprotectin. Per Mayo Medical Laboratory 
recommendations,68 stool samples of a minimum volume of 1g will be analyzed or frozen 
within 18 hours of collection. 
Data analysis 
To analyze the primary outcome, a paired t-test will be used to compare pre- and post-
dietary intervention levels of fecal calprotectin. Appropriate mean, standard deviation, 
and ranges will be calculated for fecal calprotectin as well. Statistical significance will 
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additionally be calculated using McNemar Chi-Square analysis. Absolute and relative 
risk will be calculated for pre- and post-exposure level of inflammation as well as number 
needed to treat. Multivariate analysis, specifically analysis of covariance, will be used to 
adjust for possible confounders such as age, gender, and ethnicity.  
Timeline and resources 
Table 3: Study Timeline 
Fall 2017 IRB submission and approval 
January 2018 – January 2019 Patient recruitment 
February 2019 – April 2019 Dietary intervention 
Summer 2019 Data analysis 
Manuscript submitted for peer review 
 
The primary and co-investigators will be responsible for patient education, oversight of 
the study, data collection, and data entry. A statistician will perform data analysis. We 
will need access to a laboratory assay for measurement of fecal calprotectin levels. 
Institutional Review Board 
The design of the study will be submitted for full IRB review to the Boston University 
Medical Campus IRB under INSPIR II criteria, as well as to the corresponding IRB of 
Boston Medical Center. 
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CONCLUSION 
Discussion 
The proposed study has several notable strengths when compared to prior studies of 
nutrition and intestinal pathology. First, the prospective study design will avoid recall 
bias that can confound data in retrospective studies. Our study design would also 
eliminate the ambiguity often seen in defining a vegetarian diet, which can be broken into 
several patterns including lacto-ovo vegetarian, pescatarian, and semi-vegetarian, making 
it difficult to meaningfully compare the health benefits of a vegetarian diet and a dietary 
pattern that includes animal products. Studying a vegan diet would eliminate this 
variability because of its rigid definition. 
Prior studies have also noted an attenuation of results associated with participants’ 
self-definition of their dietary pattern as vegetarian.70 Our study rigidly and quite simply 
defines the dietary pattern being investigated as one that eliminates all animal products, 
including eggs and dairy. Additionally, prior investigators report difficulty in establishing 
a classification system to characterize typical dietary patterns.20 Instead of analyzing the 
baseline dietary patterns of participants and grouping them into patterns that emerge 
within the study population, our study clearly defines the two dietary patterns we will 
investigate in order to facilitate useful comparison. It also encourages compliance with 
the intervention by supplying participants with three plant-based meals per day for the 
duration of the study period, free of charge.  
Furthermore, previous studies have noted that those identifying as vegetarians 
likely abide by other lifestyle factors which have beneficial health effects, thus making 
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the effects of diet difficult to isolate.70 This possible confounding factor would be 
eliminated by our study design because we are not studying individuals who adopt a 
plant-based diet of their own volition and are likely to be more health-conscious at 
baseline, which will conceivably yield more robust results. 
Another limitation of prior vegetarian studies has been the narrow range of intake 
of fruits and vegetables between the lowest and highest quintiles, giving a limited 
capacity to compare extremes of intake.70 Our study looks at the extremes of the plant-
food vs animal-food dichotomy and will likely have a wide range of fruit and vegetable 
intake when comparing pre-intervention diet to post-intervention diet. 
Despite these strengths, our study is not without limitations, the most prominent 
of which being recruitment from a relatively small geographical area. As all participants 
will likely be from the Northeast region of the united states, the generalizability of the 
study to other regions of the country is limited, as it is possible that environmental factors 
other than diet play a role in modulation of intestinal microflora. 
Summary 
There is substantial evidence regarding the inflammatory potential of diet. However, the 
data on effects of individual dietary components on risk of IBD and CRC has remained 
largely inconsistent, likely due to the additive and overlapping effects of individual 
micro- and macro-nutrients on both intestinal inflammation and carcinogenesis. Studies 
of an overall dietary pattern on intestinal inflammation have yielded more robust results 
than studies focusing on individual dietary components. By studying dietary patterns at 
the extreme ends of the inflammatory potential spectrum, we will both eliminate foods 
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that have been shown to have a pro-inflammatory effect on the gut and replace them with 
foods having anti-inflammatory effects, leaving little room for variability. 
Clinical and/or public health significance 
IBD and CRC are both common diseases with rising incidence rates worldwide. As they 
share the common pathogenic factor of inappropriate intestinal inflammation, an easily 
modifiable risk factor such as diet would have implications on primary prevention of both 
diseases. Data on quantifiably decreasing intestinal inflammation with dietary 
modification would also help clinicians provide evidence-based dietary recommendations 
to patients with IBD in order to reduce frequency of flares and lessen severity of 
symptoms. Dietary modification in IBD may be used in conjunction with, or even in 
place of, currently used pharmacological agents, providing an inexpensive and safe 
treatment option for control of the disease.  
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APPENDIX 
 
Food groupings used in the FFQ, adapted from Hu et al.69 
Foods or food groups Food items 
Processed meats 
Red meats 
Organ meats 
Fish and other seafood 
 
Poultry  
Eggs  
Butter  
Margarine  
Low-fat dairy products 
High-fat dairy products 
 
Liquor  
Wine  
Beer  
Tea  
Coffee  
Fruit  
 
 
 
Fruit juices 
 
Cruciferous vegetables 
 
Dark-yellow vegetables 
Processed meats, bacon, hot dogs, sausage 
Beef, pork, lamb, hamburger 
Beef, calf, pork, chicken, and turkey liver 
Canned tuna fish, dark-meat fish, other 
fish, shrimp, lobster, scallops 
Chicken or turkey with or without skin 
Eggs  
Butter  
Margarine  
Skim or low-fat milk, sherbet, yogurt 
Whole milk, cream, half and half, sour 
cream, ice cream, cream cheese, other 
cheese 
Liquor  
Red wine, white wine 
Beer  
Tea  
Coffee  
Grapes or raisins, avocado, bananas, 
cantaloupe, watermelon, fresh apples or 
pears, oranges, grapefruit, strawberries, 
blueberries, peaches, apricots, plums 
Apple juice, orange juice, grapefruit juice, 
other fruit juice 
Broccoli, cabbage, cauliflower, Brussel 
sprouts, kale, mustard greens, sauerkraut 
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Tomatoes  
 
Green, leafy vegetables 
 
Legumes  
 
Other vegetables 
 
Garlic 
Potatoes   
French fries  
Whole grains 
 
 
Cold breakfast cereal 
Refined grains 
 
 
Pizza  
Snacks  
 
Nuts  
 
 
High-energy drinks 
 
Low-energy drinks 
 
Oil and vinegar salad dressing 
Carrots, yellow squash, yams 
Tomatoes, tomato juice, tomato sauce 
Spinach, iceberg or head lettuce, romaine 
or leaf lettuce 
String beans, peas or lima beans, beans or 
lentils, tofu or soybeans, alfalfa sprouts 
Celery, mushrooms, green pepper, corn, 
mixed vegetables, eggplant, summer 
squash 
Garlic  
Potatoes  
French fries 
Cooked oatmeal, other cooked breakfast 
cereal, dark bread, brown rice, other grains, 
bran, wheat germ 
Cold breakfast cereal 
White bread, English muffins, bagels, rolls, 
muffins, biscuits, white rice, pasta, 
pancakes, waffles 
Pizza  
Potato chips, corn chips, crackers, popcorn, 
rice cakes 
Peanuts, almonds, cashews, macadamia 
nuts, pistachios, other nuts, peanut butter 
and other nut butters 
Soda with sugar, other carbonated 
beverages with sugar, fruit drinks 
Diet soda, other diet or low-sugar 
carbonated beverages 
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Mayonnaise and other creamy salad 
dressing 
Chowder or cream soup 
Other soup 
 
Sweets and desserts 
 
 
Condiments  
Oil and vinegar salad dressing 
Mayonnaise and other creamy salad 
dressings 
Chowder or cream soup 
Homemade soup, ready-made soup 
Chocolate bars or pieces, candy bars, 
cookies, brownies, doughnuts, cake, pie, 
pastries, coffee cake 
Ketchup, red chili sauce, mustard, soy 
sauce, Worcestershire sauce, jam, jelly, 
syrup, honey 
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